WallStreetZenWallStreetZen

NASDAQ: AVTE
Aerovate Therapeutics Inc Earnings & Revenue

AVTE earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$82.2M
Current Profit Margin
0%

AVTE Return on Equity

Current Company
-70.2%
Current Industry
16.8%
Current Market
28.2%
AVTE's Return on Equity (-70.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AVTE announces earnings.

AVTE Return on Assets

Current Company
-61.9%
Current Industry
3.2%
AVTE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AVTE Return on Capital Employed

Current Company
-89.95%
Current Industry
-42.4%
AVTE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AVTE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AVTE$0.00-$82.03M-$82.19MN/AN/A
MRKR$3.32M-$6.63M-$5.66M+74.37%N/A
OCUP$19.01M-$11.28M-$11.30M+468.13%N/A
CARM$15.07M-$75.99M-$81.22M-31.22%N/A
LTRN$0.00-$17.36M-$17.53MN/AN/A

AVTE earnings dates

Next earnings date
Aug 12, 2024

Aerovate Therapeutics Earnings & Revenue FAQ

What were AVTE's earnings last quarter?

On Invalid Date, Aerovate Therapeutics (NASDAQ: AVTE) reported Q1 2024 earnings per share (EPS) of -$0.83, up 23.88% year over year. Total Aerovate Therapeutics earnings for the quarter were -$23.19 million. In the same quarter last year, Aerovate Therapeutics's earnings per share (EPS) was -$0.67.

If you're new to stock investing, here's how to buy Aerovate Therapeutics stock.

What was AVTE's earnings growth in the past year?

As of Q3 2024, Aerovate Therapeutics's earnings has grown year over year. Aerovate Therapeutics's earnings in the past year totalled -$82.19 million.

What is AVTE's earnings date?

Aerovate Therapeutics's earnings date is Invalid Date. Add AVTE to your watchlist to be reminded of AVTE's next earnings announcement.

What was AVTE's revenue last quarter?

On Invalid Date, Aerovate Therapeutics (NASDAQ: AVTE) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Aerovate Therapeutics's revenue was $0.00.

What was AVTE's revenue growth in the past year?

As of Q3 2024, Aerovate Therapeutics's revenue has grown null year over year. Aerovate Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.